登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 16700 条符合本次的查询结果， 用时 1.5695095 秒

461. Point-of-Care Ultrasound in Sepsis and Septic Shock.

作者: Timothy B Kaselitz.;Christopher W Seymour.
来源: JAMA. 2025年333卷19期1720-1721页

462. Steering, Switching, and the Medicare Advantage "Trap".

作者: Lawrence P Casalino.;Amelia M Bond.;Dhruv Khullar.
来源: JAMA. 2025年333卷18期1581-1582页

463. Black Maternal Mortality Remains Disproportionately High.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1285页

464. Revising US MMR Vaccine Recommendations Amid Changing Domestic Risks.

作者: Benjamin Rader.;Rochelle P Walensky.;Wesley S Rogers.;John S Brownstein.
来源: JAMA. 2025年333卷14期1201-1202页

465. Study Finds AI Can Quickly Prescreen Patients for Clinical Trials, Speeding Enrollment.

作者: Yulin Hswen.;Nora Collins.
来源: JAMA. 2025年333卷15期1275-1277页

466. Amid Texas Measles Outbreak, Clinicians Struggle to Offset Increasing Vaccine Hesitancy.

作者: Kate Schweitzer.
来源: JAMA. 2025年333卷15期1278-1281页

467. Amid Decreasing Infant Mortality, Sleep-Related Infant Deaths Are on the Rise.

作者: Linda Rodgers.
来源: JAMA. 2025年333卷15期1282-1284页

468. Peanut Allergy Trial Shows Sustained Tolerance With Gradual Exposure.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1285-1286页

469. Semaglutide Shows Promise in Reducing Alcohol Cravings.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1285页

470. FDA Approves First Fast-Acting Insulin Biosimilar for Diabetes.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1285页

471. Certain Diabetes Medications May Help Lower COPD Exacerbation Risk.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1286页

472. Study: Bleeding Risk With Some Blood Thinners Similar to Aspirin.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷15期1285页

473. Curative Application of Immunotherapy in Untreated Head and Neck and Nasopharynx Cancer.

作者: Marshall Posner.
来源: JAMA. 2025年333卷18期1584-1585页

474. High-Intensity vs Low-Intensity Noninvasive Positive Pressure Ventilation and Need for Endotracheal Intubation-Reply.

作者: Zujin Luo.;Yichong Li.;Zhixin Cao.
来源: JAMA. 2025年333卷14期1262-1263页

475. Incorrect Data Sharing Statement.

来源: JAMA. 2025年333卷14期1263页

476. Attributes of a Rejected Manuscript.

来源: JAMA. 2025年333卷14期1266页

477. What Is Dialysis?

作者: Rebecca Voelker.
来源: JAMA. 2025年333卷19期1752页

478. High-Intensity vs Low-Intensity Noninvasive Positive Pressure Ventilation and Need for Endotracheal Intubation.

作者: Joseph R Shiber.
来源: JAMA. 2025年333卷14期1262页

479. Fireflies.

作者: Julia L McDonald.
来源: JAMA. 2025年333卷14期1265页

480. Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

作者: Robert Haddad.;Jérôme Fayette.;Maria Teixeira.;Kumar Prabhash.;Ricard Mesia.;Andrzej Kawecki.;Arunee Dechaphunkul.;José Dinis.;Ye Guo.;Muneyuki Masuda.;Ching-Yun Hsieh.;Maria Grazia Ghi.;Claudia Vaz de Melo Sette.;Kevin Harrington.;Makoto Tahara.;Nabil F Saba.;Agnes Lau.;Tao Jiang.;Yibing Yan.;Marcus Ballinger.;Monika Kaul.;Christina Matheny.;Vaikunth Cuchelkar.;Deborah J Wong.
来源: JAMA. 2025年333卷18期1599-1607页
Treating locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) involves any combination of surgery, radiation, and chemotherapy, followed by routine monitoring for local recurrence or distant metastases. Given the poor patient outcomes, a significant unmet clinical need for improved treatment options remains.
共有 16700 条符合本次的查询结果， 用时 1.5695095 秒